4.7 Article

Emergence of Serotype IV Group B Streptococcus Adult Invasive Disease in Manitoba and Saskatchewan, Canada, Is Driven by Clonal Sequence Type 459 Strains

Journal

JOURNAL OF CLINICAL MICROBIOLOGY
Volume 53, Issue 9, Pages 2919-2926

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.01128-15

Keywords

-

Categories

Funding

  1. Public Health Ontario

Ask authors/readers for more resources

Serotype IV group B Streptococcus (GBS) is emerging in Canada and the United States with rates as high as 5% of the total burden of adult invasive GBS disease. To understand this emergence, we studied the population structure and assessed the antimicrobial susceptibility of serotype IV isolates causing adult invasive infection in Manitoba and Saskatchewan, Canada, between 2010 and 2014. Whole-genome sequencing was used to determine multilocus sequence typing information and identify genes encoding antimicrobial resistance in 85 invasive serotype IV GBS strains. Antimicrobial susceptibility testing was performed by standard methods. Strain divergence was assessed using genome-wide single-nucleotide polymorphism analysis. Serotype IV strains were responsible for 16.9% of adult invasive GBS infections in Manitoba and Saskatchewan during the period. The majority of serotype IV isolates (89%) were clonally related, tetracycline-, erythromycin-, and clindamycin-resistant sequence type 459 (ST459) strains that possessed genes tetM and ermTR. Genome comparisons between ST459 and serotype V ST1 GBS identified several areas of recombination in an overall similar genomic background. Serotype IV ST459 GBS strains are expanding and causing a substantial percentage of adult invasive GBS disease. This emergence may be linked to the acquisition of resistance to tetracycline, macrolides, and lincosamides.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

Similar duration of viral shedding of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant between vaccinated and incompletely vaccinated individuals

Christopher E. Kandel, Andra Banete, Maureen Taylor, Andrea Llanes, Janine McCready, Gloria Crowl, Matthew Young, Angel X. Li, Emily Chien, Winfield Yim, Lily Yip, Robert Kozak, Allison J. McGeer, Samira Mubareka, Jeff E. Powis

Summary: There was no difference in viral shedding between outpatients with coronavirus disease 2019 (COVID-19) due to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta (delta) variant who received 2 vaccine doses at 7 days after symptom onset and those who did not receive the vaccine, with SARS-CoV-2 cultured from 2 (7%) of 28 and 1 (4%) of 26 outpatients, respectively.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Letter Public, Environmental & Occupational Health

Severity of SARS-CoV-2 omicron infection in vaccinated and unvaccinated residents of long-term care homes

Ahmed Vanker, Lara de Waal, Allison McGeer, Matthew Morgan

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Letter Immunology

Environmental Testing of Surfaces in the Room of a Patient With Monkeypox

Matthew P. Muller, Sharmistha Mishra, Allison McGeer, Samir Patel, Jonathan Gubbay, Maan Hasso, Adrienne K. Chan, Robert Kozak, Jerome A. Leis, Darrell S. Tan

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection From the Canadian National Vaccine Safety Network

Julie A. Bettinger, Michael A. Irvine, Hennady P. Shulha, Louis Valiquette, Matthew P. Muller, Otto G. Vanderkooi, James D. Kellner, Karina A. Top, Manish Sadarangani, Allison McGeer, Jennifer E. Isenor, Kimberly Marty, Phyumar Soe, Gaston De Serres

Summary: This study examined the short-term safety of COVID-19 vaccines in adults with a previous history of SARS-CoV-2 infection. It found that adults with moderate or severe previous infection were more likely to experience health events after each vaccine dose, while the risk associated with previous infection was attenuated after subsequent doses.

CLINICAL INFECTIOUS DISEASES (2023)

Article Genetics & Heredity

Genome screening, reporting, and genetic counseling for healthy populations

Selina Casalino, Erika Frangione, Monica Chung, Georgia MacDonald, Sunakshi Chowdhary, Chloe Mighton, Hanna Faghfoury, Yvonne Bombard, Lisa Strug, Trevor J. Pugh, Jared Simpson, Saranya Arnoldo, Navneet Aujla, Erin Bearss, Alexandra Binnie, Bjug Borgundvaag, Howard Chertkow, Marc Clausen, Marc Dagher, Luke Devine, David Di Iorio, Steven Marc Friedman, Chun Yiu Jordan Fung, Anne-Claude Gingras, Lee W. Goneau, Deepanjali Kaushik, Zeeshan Khan, Elisa Lapadula, Tiffany Lu, Tony Mazzulli, Allison McGeer, Shelley L. McLeod, Gregory Morgan, David Richardson, Harpreet Singh, Seth Stern, Ahmed Taher, Iris Wong, Natasha Zarei, Elena Greenfeld, Limin Hao, Matthew Lebo, William Lane, Abdul Noor, Jennifer Taher, Jordan Lerner-Ellis

Summary: Rapid advancements in genome sequencing technology have improved our understanding of the relationship between genes and human disease. This study collected blood samples from COVID-19 patients and performed genome sequencing to analyze the data. The researchers developed a comprehensive report that includes information on disease risks, genetic variants, and ancestry. They emphasize the importance of genetic counseling and offer counseling and referrals for clinically significant findings.

HUMAN GENETICS (2023)

Article Immunology

Invasive Pneumococcal Disease in High-risk Children: A 10-Year Retrospective Study

Jacqui van Warmerdam, Aaron Campigotto, Ari Bitnun, Georgina MacDougall, Melanie Kirby-Allen, Blake Papsin, Allison McGeer, Upton Allen, Shaun K. Morris

Summary: Despite the availability of pneumococcal vaccines, children with high-risk conditions are still susceptible to invasive pneumococcal disease. Insufficient vaccination is the main factor contributing to the occurrence of the disease.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2023)

Article Pediatrics

Evolving antibiotic resistance in Group B Streptococci causing invasive infant disease: 1970-2021

Elizabeth Marie Sabroske, Misu Ailin Sanson Iglesias, Marcia Rench, Trevor Moore, Hanna Harvey, Morven Edwards, Carol J. Baker, Anthony R. Flores

Summary: This study investigated the changes in antibiotic resistance of a collection of GBS isolates over time and found a significant increase in clindamycin and erythromycin resistance. Obstetricians should be aware of this trend for penicillin-allergic women who may consider using clindamycin.

PEDIATRIC RESEARCH (2023)

Correction Microbiology

Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission (vol 7, pg 2011, 2022)

Bradley Pickering, Oliver Lung, Finlay Maguire, Peter Kruczkiewicz, Jonathon D. Kotwa, Tore Buchanan, Marianne Gagnier, Jennifer L. Guthrie, Claire M. Jardine, Alex Marchand-Austin, Ariane Masse, Heather McClinchey, Kuganya Nirmalarajah, Patryk Aftanas, Juliette Blais-Savoie, Hsien-Yao Chee, Emily Chien, Winfield Yim, Andra Banete, Bryan D. Griffin, Lily Yip, Melissa Goolia, Matthew Suderman, Mathieu Pinette, Greg Smith, Daniel Sullivan, Josip Rudar, Oksana Vernygora, Elizabeth Adey, Michelle Nebroski, Guillaume Goyette, Andres Finzi, Genevieve Laroche, Ardeshir Ariana, Brett Vahkal, Marceline Cote, Allison J. McGeer, Larissa Nituch, Samira Mubareka, Jeff Bowman

NATURE MICROBIOLOGY (2023)

Article Immunology

Evaluating the Impact of Statin Use on Influenza Vaccine Effectiveness and Influenza Infection in Older Adults

Hannah Chung, Michael A. Campitelli, Sarah A. Buchan, Aaron Campigotto, Branson Chen, Natasha S. Crowcroft, Vinita Dubey, Jonathan B. Gubbay, Timothy Karnauchow, Kevin Katz, Allison J. McGeer, J. Dayre McNally, Samira Mubareka, Michelle Murti, David C. Richardson, Laura C. Rosella, Kevin L. Schwartz, Marek Smieja, George Zahariadis, Jeffrey C. Kwong

Summary: The effectiveness of influenza vaccine against laboratory-confirmed influenza was similar between statin users and nonusers. However, statin users had a higher risk of influenza infection compared to nonusers, regardless of vaccination status. This study suggests that statin use may affect the effectiveness of influenza vaccine and increase the risk of influenza infection.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Increases in Group A Streptococcal Infections in the Pediatric Population in Houston, Texas, 2022

Aya Aboulhosn, Misu A. Sanson, Luis Alberto Vega, Maria G. Segura, Sommer Sommer, Marritta Joseph, J. Chase McNeil, Anthony R. Flores

Summary: Starting from October 2022, there has been a notable rise in the number of cases of invasive group A Streptococcus (GAS) disease among children in Houston, Texas. The prevalence of Emm12 GAS strains was disproportionately higher, but the overall proportion of invasive GAS infections during the current surge remains similar to pre-pandemic years.

CLINICAL INFECTIOUS DISEASES (2023)

Article Public, Environmental & Occupational Health

Coronavirus disease 2019 (COVID-19) outbreak on an in-patient medical unit associated with unrecognized exposures in common areas-Epidemiological and whole-genome sequencing investigation

Dylan C. Kain, Sandra Isabel, Mariana Abdulnoor, Karel Boissinot, Richard De Borja, Amanda Filkin, Bernard Lam, Jason Li, Ilinca Lungu, Liz McCreight, Allison McGeer, Tony Mazzulli, Aimee Paterson, Philip Zuzarte, Felicia Vincelli, Cassandra Bergwerff, Ramzi Fattouh, Jared T. Simpson, Jennie Johnstone

Summary: During the COVID-19 pandemic, a severe SARS-CoV-2 outbreak occurred in a hospital in Toronto, Canada, from November 2020 to January 2021. The outbreak involved 8 patients and 10 staff and resulted in 3 patient deaths. Investigation revealed that patients cared for in geriatric chairs at the nursing station were at high risk for both acquiring and transmitting SARS-CoV-2. Therefore, it is important to consider the risk of informal patient care settings and prioritize room-based care during high-risk periods or outbreaks.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Microbiology

Hyperphosphorylation of the Group A Streptococcal Control of Virulence Regulator Increases Promoter Occupancy Specifically at Virulence Factor-Encoding Genes

Nicola Horstmann, Chau Nguyen Tran, Anthony R. Flores, Samuel A. Shelburne

Summary: The CovRS gene regulatory system plays a critical role in the pathogenesis of many streptococci. In this study, the researchers used chromatin immunoprecipitation sequencing (ChIPseq) to investigate the global DNA occupancy of CovR in emm3 group A streptococci. They found that elimination of CovS phosphatase activity increased CovR occupancy at the promoters of virulence factor-encoding genes, including the key regulator Mga and M protein. The study also identified different binding patterns of CovR at high and low phosphorylation levels, suggesting a dimeric and monomeric interaction, respectively.

JOURNAL OF BACTERIOLOGY (2023)

Article Economics

The epidemiology and healthcare costs of community-acquired pneumonia in Ontario, Canada: a population-based cohort study

Ryan O'Reilly, Hong Lu, Jeffrey C. C. Kwong, Allison McGeer, Teresa To, Beate Sander

Summary: The present study aimed to determine the short- and long-term healthcare costs associated with community-acquired pneumonia (CAP) from the healthcare payer perspective in Ontario, Canada. Through a retrospective population-based matched cohort study, it was found that CAP is associated with significantly increased acute and long-term healthcare costs compared to unexposed subjects. This study highlights the burden of CAP in both the inpatient and outpatient setting, and will inform strategic healthcare planning for future interventions and healthcare programs.

JOURNAL OF MEDICAL ECONOMICS (2023)

Article Infectious Diseases

Use of whole genome sequencing to identify low-frequency mutations in SARS-CoV-2 patients treated with remdesivir

Kuganya Nirmalarajah, Winfield Yim, Patryk Aftanas, Angel X. Li, Altynay Shigayeva, Lily Yip, Zoe Zhong, Allison J. Mcgeer, Finlay Maguire, Samira Mubareka, Robert Kozak

Summary: This study investigated the effects of Remdesivir (RDV) treatment on intra-host SARS-CoV-2 diversity and low-frequency mutations in moderately ill hospitalized COVID-19 patients. The results showed minimal intra-host variability and few low-frequency variants in patients receiving short courses of RDV, suggesting little selective pressure.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2023)

Article Microbiology

Temporal dynamics of genetically heterogeneous extended-spectrum cephalosporin-resistant Escherichia coli bloodstream infections

William C. Shropshire, Benjamin Strope, Selvalakshmi Selvaraj Anand, Jordan Bremer, Patrick McDaneld, Micah M. Bhatti, Anthony R. Flores, Awdhesh Kalia, Samuel A. Shelburne

Summary: Using whole-genome sequencing, this study characterized the molecular epidemiology of extended-spectrum cephalosporin-resistant Escherichia coli (ESC-R-Ec) infections at a cancer center in Houston. The study identified a temporal dynamic of ESC-R-Ec infections, with peaks occurring in the last 6 months of the year, and a stable proportion of STc131 strains throughout the study period. The study also revealed the presence of genetically diverse ESC-R-Ec clonal complexes during infection peaks.

MSPHERE (2023)

No Data Available